These outcomes suggest a potential association, indicating that peripheral blood NK cells might serve as a surrogate for evaluating KIR3DL2 expression on NK cells within tumor tissues, offering promise in prognosticating patient outcomes. Here, KIR3DL2 is linked to neoplasm.